Pretransplant Induction Regimens for Multiple Myeloma

被引：1
|
作者：
Vesole, David H. [1 ]
Siegel, David S. [1 ]
机构：
[1] Hackensack UMC, Hackensack, NJ 07601 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2015年 / 21卷 / 02期
关键词：
STEM-CELL TRANSPLANTATION; DISEASE; SINGLE;
D O I：
10.1016/j.bbmt.2014.12.013
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：200 / 201
页数：2
相关论文
共 50 条
  • [21] AVAILABILITY AND REIMBURSEMENT OF MULTIPLE MYELOMA DRUG REGIMENS IN SPAIN
    Garrido Alejos, G.
    Vallez, L.
    Saborit-Canals, G.
    Gaso Gago, I
    Lizano Gispert, E.
    Roig, M.
    Pontes, C.
    Feliu Ribera, A.
    Vallano Ferraz, A.
    VALUE IN HEALTH, 2022, 25 (12) : S250 - S250
  • [22] BORTEZOMIB-BASED REGIMENS AS INDUCTION AND MAINTENANCE TREATMENT IN MULTIPLE MYELOMA (MM) PATIENTS NOT ELIGIBLE FOR AGGRESSIVE THERAPY
    Mazzone, C.
    Gentile, M.
    Vigna, E.
    Lucia, E.
    Lorio, C.
    Morelli, R.
    Bisconte, M. G.
    Gentile, C.
    Morabito, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 544 - 544
  • [23] Toxicity of autologous hematopoietic cell transplantation in patients with multiple myeloma - comparison between two different induction regimens
    Ram, Ron
    Magen-Nativ, Hila
    Vidal, Liat
    Herscovici, Corina
    Peck, Anat
    Raanani, Pia
    Shpilberg, Ofer
    Yeshurun, Moshe
    CLINICAL TRANSPLANTATION, 2012, 26 (05) : E549 - E554
  • [24] Kinetics of Response to Bortezomib/Thalidomide/Dexamethasone (VTD) in Multiple Myeloma: Implications for the Choice and Design of Pretransplantation Induction Regimens
    Rosinol, Laura
    Oriol, Albert
    Teruel, Ana Isabel
    Hernandez, Dolores
    Jesus Blanchard, M.
    De La Rubia, Javier
    Granell, Miquel
    Besalduch, Juan
    Palomera, Luis
    Gonzalez, Yolanda
    Ma Asuncion, Etxebeste
    Diaz-Mediavilla, Joaquin
    Hernandez, Miguel T.
    de Arriba, Felipe
    Carmen Gutierrez, Norma
    Mateos, Maria-Victoria
    Martinez-Lopez, Joaquin
    Alegre, Adrian
    Feng, Huaibao
    van de Velde, Helgi
    Jose Lahuerta, Juan
    San Miguel, Jesus F.
    Blade, Joan
    BLOOD, 2014, 124 (21)
  • [25] INDUCTION AND DEVELOPMENT OF MULTIPLE-MYELOMA
    KIMURA, I
    MIGITA, S
    ACTA HAEMATOLOGICA JAPONICA, 1986, 49 (02): : 210 - 210
  • [26] Improving Induction Therapy in Multiple Myeloma
    Nooka, Ajay
    Gleason, Charise
    Lonial, Sagar
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2010, 5 (03) : 119 - 128
  • [27] Induction of pyroptosis for the treatment of multiple myeloma
    Mao, Xinliang
    He, Yuanming
    Jiang, Shuoyi
    Huang, Zhenqian
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S146 - S146
  • [28] Improving Induction Therapy in Multiple Myeloma
    Ajay Nooka
    Charise Gleason
    Sagar Lonial
    Current Hematologic Malignancy Reports, 2010, 5 : 119 - 128
  • [29] Bortezomib and dexamethasone induction for multiple myeloma
    Jacob Laubach
    Paul Richardson
    Nature Reviews Clinical Oncology, 2011, 8 : 8 - 10
  • [30] VTD (Bortezomib/Thalidomide/Dexamethasone) As Pretransplant Induction Therapy for Multiple Myeloma: Definitive Results of a Randomized Phase 3 Pethema/GEM Study
    Rosinol Dachs, Laura
    Oriol, Albert
    Isabel Teruel, Ana
    Lopez de la Guia, Ana
    Jesus Blanchard, M.
    Jarque, Isidro
    Granell, Miquel
    Sampol, Antonia
    Palomera, Luis
    Gonzalez-Montes, Yolanda
    Bengoechea, Enrique
    Martinez-Martinez, Rafael
    Hernandez, Miguel T.
    De Arriba, Felipe
    Luisa Martin-Ramos, Maria
    Gutierrez, Norma C.
    Teresa Cibeira, Maria
    Mateos, Maria-Victoria
    Martinez-Lopez, Joaquin
    Alegre, Adrian
    Jose Lahuerta, Juan
    San-Miguel, Jesus F.
    Blade, Joan
    BLOOD, 2018, 132
12345